Translate this page into:
Urinary Incontinence Induced by Tramadol
Address for correspondence: Dr. Sujeet Kumar Singh Gautam; E-mail: docsksg@gmail.com
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
Sir,
Tramadol is a centrally acting opioid analgesic; it is a μ-receptor agonist and inhibits reuptake of serotonin and norepinephrine.[1] The antimuscarinic effect of tramadol is helpful in patients with detrusor overactivity;[2] however, urinary incontinence has not been mentioned as a side effect associated with tramadol use.
A 63-year-old female presented in our pain clinic with cancer pain secondary to carcinoma buccal mucosa; we prescribed a combination of acetaminophen (325 mg) with tramadol (37.5 mg) q.i.d. However, the patient complained of urinary incontinence while sleeping in the night two days after starting this treatment. The postvoided residue was nil in this case, which delineated the possibility of overflow incontinence; in addition, there was no past history of urinary incontinence. Incontinence disappeared after treatment was stopped. We encountered similar problem in 3-4 patients in the elderly age-group.
Tramadol decreases pelvic floor electromyography (EMG) activity; the possible explanation is modulation of proprioceptive afferent inputs from the pelvic floor by tramadol at the dorsal horn level, which are important in maintaining muscle tone, and hence EMG activity.[3] Literature also suggests presence of prejunctional serotonin receptors at parasympathetic nerve terminals in the human bladder.[4] These receptors are involved in both positive (5-HT4 and 5-HT7) and negative (5-HT1A) feedback mechanisms regulating cholinergic transmission; activation of excitatory serotonin receptors may cause reflex relaxation of the urethral sphincter along with detrusor contraction. Thus, parasympathetic hyperactivity with pelvic floor relaxation might have contributed to urinary incontinence in these cases. Hence, possibility of urinary incontinence should always be kept in mind while using tramadol, especially in population prone to urinary incontinence. However, molecular studies of greater magnitude investigating the pelvic floor neurophysiology are required.
REFERENCES
- Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic. J Pharmacol Exp Ther. 1992;260:275-85.
- [Google Scholar]
- The inhibitory effects of tramadol on muscarinic receptor-induced responses in Xenopus oocytes expressing cloned M (3) receptors. Anesth Analg. 2002;95:1269-73.
- [Google Scholar]
- Effect of lumbar-epidural administration of tramadol on lower urinary tract function. Neurourol Urodyn. 2008;27:65-70.
- [Google Scholar]
- Characterization of prejunctional serotonin receptors modulating [3H] acetylcholine release in human detrusor. J Pharmacol Exp Ther. 2006;316:129-35.
- [Google Scholar]